The world is waiting with bated breath for a successful COVID-19 vaccine. But even if one does become available there will still be a need for effective treatments. Details from a clinical study of a breakthrough drug appear to show some promise. And as Linda Aylesworth reports it all began with a UBC researcher’s work on the SARS outbreak 15 years ago
- Eli Lilly to resume some coronavirus antibody-drug trials after safety concerns
- UBC professor uses knowledge of SARS to develop COVID-19 drug